JN Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 86: 3061-3064, 2001;
0022-3077/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelly, S.
Right arrow Articles by Chapman, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelly, S.
Right arrow Articles by Chapman, V.

The Journal of Neurophysiology Vol. 86 No. 6 December 2001, pp. 3061-3064
Copyright ©2001 by the American Physiological Society

RAPID COMMUNICATION

Selective Cannabinoid CB1 Receptor Activation Inhibits Spinal Nociceptive Transmission In Vivo

Sara Kelly and Victoria Chapman

School of Biomedical Sciences, University of Nottingham Medical School, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom

Kelly, Sara and Victoria Chapman. Selective Cannabinoid CB1 Receptor Activation Inhibits Spinal Nociceptive Transmission In Vivo. J. Neurophysiol. 86: 3061-3064, 2001. Cannabinoid1 (CB1) receptors are located at CNS sites, including the spinal cord, involved in somatosensory processing. Analgesia is one of the tetrad of behaviors associated with cannabinoid agonists. Here, effects of a potent cannabinoid CB1 receptor agonist arachidonyl-2-chloroethylamide (ACEA) on evoked responses of dorsal horn neurons in anesthetized rats were investigated. Extracellular recordings of convergent dorsal horn neurons were made in halothane anesthetized Sprague-Dawley rats (n = 16). Effects of spinal application of ACEA on electrically evoked responses of dorsal horn neurons were studied. Mean maximal effects of 0.5, 5, 50, and 500 ng/50 µl ACEA on the C-fiber-mediated postdischarge response were 79 ± 6, 62 ± 10, and 54 ± 7% (P < 0.01), 45 ± 6% (P < 0.01), of control, respectively. ACEA (500 ng/50 µl) also reduced the C-fiber-evoked nonpotentiated responses of neurons (59 ± 9% of control, P < 0.05) and Adelta -fiber-evoked responses of neurons (68 ± 10% of control, P < 0.01). Minor effects of ACEA on Abeta -fiber-evoked responses were observed. Spinal pre-administration of the selective CB1 receptor antagonist SR141716A (0.01 µg/50 µl) significantly reduced effects of ACEA (500 ng/50 µl) on postdischarge responses of dorsal horn neurons. This study demonstrates that spinal CB1 receptors modulate the transmission of C- and Adelta -fiber-evoked responses in anesthetized rats; this may reflect pre- and/or postsynaptic effects of cannabinoids on nociceptive transmission. CB1 receptors inhibit synaptic release of glutamate in rat dorsolateral striatum, a similar mechanism of action may underlie the effects of ACEA on noxious evoked responses of spinal neurons reported here.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S. Akerman, P. R. Holland, and P. J. Goadsby
Cannabinoid (CB1) Receptor Activation Inhibits Trigeminovascular Neurons
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 64 - 71.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
L. M. Johanek and D. A. Simone
Cannabinoid Agonist, CP 55,940, Prevents Capsaicin-Induced Sensitization of Spinal Cord Dorsal Horn Neurons
J Neurophysiol, February 1, 2005; 93(2): 989 - 997.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
A. G. Nackley, A. M. Zvonok, A. Makriyannis, and A. G. Hohmann
Activation of Cannabinoid CB2 Receptors Suppresses C-Fiber Responses and Windup in Spinal Wide Dynamic Range Neurons in the Absence and Presence of Inflammation
J Neurophysiol, December 1, 2004; 92(6): 3562 - 3574.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
V. C. J. Wallace, D. F. Cottrell, P. J. Brophy, and S. M. Fleetwood-Walker
Focal Lysolecithin-Induced Demyelination of Peripheral Afferents Results in Neuropathic Pain Behavior That Is Attenuated by Cannabinoids
J. Neurosci., April 15, 2003; 23(8): 3221 - 3233.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. M. Rawls, A. Cowan, R. J. Tallarida, E. B. Geller, and M. W. Adler
N-Methyl-D-aspartate Antagonists and WIN 55212-2 [4,5-Dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a Cannabinoid Agonist, Interact to Produce Synergistic Hypothermia
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 395 - 402.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online